US Patent 9199968 Therapeutic compounds and compositions
Patent 9199968 was granted and assigned to Agios Pharmaceuticals on December, 2015 by the United States Patent and Trademark Office.
All edits
Edits on 12 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 3 Dec, 2023
Golden AI
Edits made to:
Article (+228 characters)
Article
Patent abstract
Compounds and compositions comprising compounds that modulate pyruvate kinase M2 (PKM2) are described herein. Also described herein are methods of using the compounds that modulate PKM2 in the treatment of cancer.
Edits on 19 Jul, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09199968 Therapeutic compounds and compositions US Patent 9199968 Therapeutic compounds and compositions
Infobox
Patent Number
091999680
Patent Number
91999680
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
091999680
Date of Patent
December 1, 2015
0Patent Application Number
145058660
Date Filed
October 3, 2014
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 4 Jan, 2022
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 09199968 Therapeutic compounds and compositions
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
09199968
Date of patent
December 1, 2015
Patent application number
14505866
Date Filed
October 3, 2014
Patent primary examiner
Find more entities like US Patent 9199968 Therapeutic compounds and compositions
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
